MARKET

BWAY

BWAY

Brainsway
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.04
+0.05
+0.83%
Closed 16:00 07/02 EDT
OPEN
6.18
PREV CLOSE
5.99
HIGH
6.20
LOW
6.04
VOLUME
4.51K
TURNOVER
--
52 WEEK HIGH
12.53
52 WEEK LOW
5.10
MARKET CAP
67.20M
P/E (TTM)
-6.0400
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BWAY stock price target is 12.01 with a high estimate of 13.00 and a low estimate of 10.00.

EPS

BWAY News

More
BrainsWay Ltd. (BWAY) CEO Christopher von Jako on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 06/25 11:24
BrainsWay Sees Q2 Sales $4.6M-$4.9M
Benzinga · 06/24 11:34
Brainsway Q1 EPS $(0.15), Inline, Sales $4.16M Miss $4.55M Estimate
Brainsway (NASDAQ:BWAY) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. The company reported quarterly sales of $4.16 million which missed the analyst consensus estimate of $4.55
Benzinga · 06/24 11:33
BrainsWay Reports First Quarter 2020 Financial Results and Operational Highlights
PATTERSON, N.J. and JERUSALEM, June 24, 2020 -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment.
GlobeNewswire · 06/24 11:30
BrainsWay Launches New Website To Enhance Mental Health Awareness
PATTERSON, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in the advanced noninvasive treatment of brain
Benzinga · 06/16 11:32
BrainsWay Launches New Website to Enhance Mental Health Awareness
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced the launch of its newly redesigned website. The new site features a modern and user-friendly layout,
GlobeNewswire · 06/16 11:30
BrainsWay to Report First Quarter 2020 Financial Results and Operational Highlights on June 24, 2020
GlobeNewswire · 06/09 12:30
BrainsWay Strengthens Senior Leadership Team with Appointment of Christopher Boyer as Vice President of Global Marketing
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced the appointment of Christopher Boyer as Vice President of Global Marketing. Mr. Boyer will be respo
GlobeNewswire · 05/20 11:30

Industry

Biotechnology & Medical Research
+0.68%
Pharmaceuticals & Medical Research
+0.61%

Hot Stocks

Symbol
Price
%Change

About BWAY

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system is used in various clinical applications, including major depression, bi-polar disorders, obesity, eating disorders, schizophrenia, Parkinson's disease, Altzheimer's disease, stroke rehabilitation, post-traumatic stress disorder, chronic pain, drug addiction, smoking cessation, epilepsy, migraine, tourette syndrome, uncontrolled blinking, autism, and multiple sclerosis.
More

Webull offers kinds of Brainsway Ltd stock information, including NASDAQ:BWAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BWAY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BWAY stock methods without spending real money on the virtual paper trading platform.